跳至主要内容
临床试验/PACTR202607847734586
PACTR202607847734586进行中(未招募)不适用

Bioequivalence of a Locally Manufactured Brand of Enalapril 10mg Tablet: A Randomized, Open-Label, Non-Replicated, Two-Sequence, Two-Period Crossover Pilot Study for the Introduction of Bioequivalence Studies in East Africa

KENYA MEDICAL RESEARCH INSTITUTE0 个研究点目标入组 16 人开始时间: 2026年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 44 Year(s)(—)
性别
Male

入选标准

  • Biological male sex
  • Age between 18 to 55 years (both inclusive)
  • Has a BMI of 20 to 30 kg/m2 (both inclusive)
  • Willing and able to provide informed consent

排除标准

  • History of drug abuse or alcohol abuse.
  • Current medical treatment or treatment in the last one week.
  • Current acute or chronic illness
  • Laboratory findings suggestive of liver disease, kidney disease, blood disorder or systemic infection
  • Currently enrolled in another interventional trial with an investigational product.

研究者

相似试验

招募中
4 期
Evaluation of bioequivalence of two products containing estradiol: Estradiol/INTERMED gel 0.1% w/w (Test) vs. ESTREVA 0.1% gel (Comparator). An open, randomized, single-dose, four-period, full-replicative trial in healthy postmenopausal womenNo therapeutic indication in the current trial with healthy volunteers.
2025-524775-23-00CCDRD Cooperative Clinical Drug Research and Development AG, Ioulia And Irene Tseti Pharmaceutical Laboratories S.A.140
招募中
4 期
Evaluation of bioequivalence of two products containing 600 mg ibuprofen: Ibuprofen Sopharma 600 mg film-coated tablets (Test) vs. Brufen 600 mg film-coated tablets (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
2025-520572-25-00CCDRD Cooperative Clinical Drug Research and Development AG, Sopharma AD30
已完成
4 期
Bioequivalence study of a proposed biosimilar insulin glargine U300 with Toujeo®Type 1 Diabetes Mellitus
2023-504509-36-00Biocon Sdn. Bhd.68
进行中(未招募)
1 期
A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Vortioxetine 20 mg Tablets relative to Brintellix (Vortioxetine tablets 20mg), in healthy Thai participants under fasting conditionTreating of major depressive disorder (MDD).Bioequivalence Vortioxetine 20 mg Tablets
TCTR20260710024Bio-innova Co., Ltd.30
已完成
1 期
Pharmacokinetics and Bioequivalence Study of HMPL-523 Acetate Tablets in Humans
NCT07331194Hutchmed54